Marshall Wace’s Eiger BioPharmaceuticals, Inc. EIGR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-833
| Closed | -$22.5K | – | 2759 |
|
|
2023
Q1 | $22.5K | Hold |
833
| – | – | ﹤0.01% | 2063 |
|
|
2022
Q4 | $29.5K | Buy |
+833
| New | +$29.5K | ﹤0.01% | 2255 |
|
|
2022
Q2 | – | Sell |
-1,144
| Closed | -$285K | – | 3418 |
|
|
2022
Q1 | $285K | Buy |
+1,144
| New | +$285K | ﹤0.01% | 2280 |
|
|
2020
Q4 | – | Sell |
-2,856
| Closed | -$698K | – | 2131 |
|
|
2020
Q3 | $698K | Buy |
2,856
+1,079
| +61% | +$264K | ﹤0.01% | 1107 |
|
|
2020
Q2 | $512K | Sell |
1,777
-1,041
| -37% | -$300K | ﹤0.01% | 1164 |
|
|
2020
Q1 | $575K | Buy |
+2,818
| New | +$575K | 0.01% | 939 |
|
|
2019
Q4 | – | Sell |
-177
| Closed | -$55K | – | 2101 |
|
|
2019
Q3 | $55K | Buy |
+177
| New | +$55K | ﹤0.01% | 1434 |
|